Providence Health & Services
Also known as: Providence Cancer Center | Providence Cancer Center, Earle A. Chiles Research Institute | Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center | Providence Cancer Center, Earle A. Chiles Reserach Institute at the Robert W. Franz Cancer Center | Providence Health and Services | Providence Healthcare | Providence Health Care and UBC | Providence Health & Services | Providence Health & Services Brain & Spine Institute | Providence Medical Group Infectious Disease | Providence Portland / Robert W. Franz Cancer Research Center
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1996Last known activity
Feb 28, 2025
Timeline
1850s
- Jan 1, 1859
Providence Health & Services— Founded
Drugs by trial phase (105 distinct, 77 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (47 own, 0 via acquisition)
Phase 1 (39 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Astrocytoma
- Bipolar Disorder
- Brain Neoplasms
- Breast Diseases
- Breast Neoplasms
- Breast Neoplasms, Male
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Coronavirus Infections
- Depression
- Depressive Disorder
- Fatigue
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Kidney Neoplasms
- Lung Neoplasms
- Melanoma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Neoplasm Metastasis
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Neoplasms, Second Primary
- Neoplasms, Squamous Cell
- Pancreatic Diseases
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Rectal Neoplasms
- Sarcoma
- Sclerosis
- Severe Acute Respiratory Syndrome
- Skin Diseases
- Skin Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Virus Diseases
Recent trials (50)
- NCT05389514Lead sponsorN/A—
- NCT05389514Overall official - principal investigatorN/A—
- NCT06719362Lead sponsorPhase 1Feb 28, 2025
- NCT06719362OfficialPhase 1Feb 28, 2025
- NCT06353997Lead sponsorPhase 2Sep 5, 2024
- NCT06353997OfficialPhase 2Sep 5, 2024
- NCT06626152CollaboratorPhase 2Aug 15, 2024
- NCT06175000Overall official - principal investigatorPhase 2Jan 2, 2024
- NCT06175000Lead sponsorPhase 2Jan 2, 2024
- NCT05913388CollaboratorPhase 2Dec 31, 2023
- NCT05913388Overall official - principal investigatorPhase 2Dec 31, 2023
- NCT05913388Lead sponsorPhase 2Dec 31, 2023
- NCT05913388CollaboratorPhase 2Dec 31, 2023
- NCT05822609CollaboratorPhase 2Nov 30, 2023
- NCT05822609Overall official - principal investigatorPhase 2Nov 30, 2023
Details
- Founded
- Renton, WA, US Jan 1, 1859
- Last known activity
- Feb 28, 2025